Prevalence of periprosthetic osteolysis after total hip replacement in patients with rheumatic diseases
Rodolfo Perez Alamino, Carolina Casellini, Andrea Banos, Emilce Edith Schneeberger, Susana Alicia Gagliardi, José Antonio Maldonado Cocco, Gustavo CiteraSection of Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, ArgentinaAbstract: Per...
Guardado en:
Autores principales: | Perez Alamino R, Casellini C, Baňos A, Schneeberger EE, Gagliardi SA, Maldonado Cocco JA, Citera G |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b820e7925bf942efbdaa70f3144b652b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Long-term use of adalimumab in the treatment of rheumatic diseases
por: Charalampos Papagoras, et al.
Publicado: (2009) -
The role of adalimumab in rheumatic and autoimmune disorders: comparison with other biologic agents
por: Reimold AM
Publicado: (2012) -
COVID-19 and Autoimmune/Autoinflammatory Rheumatic Disease Patients: Lessons Learned and Questions Anticipating Answers
por: Athanasios-Dimitrios Bakasis, et al.
Publicado: (2021) -
Perceptions of Physical Activity and the Use of Activity Monitors to Increase Activity Levels in Patients Undergoing Total Knee Replacement
por: Kaetlyn R. Arant, et al.
Publicado: (2021) -
Factors Associated With Hospitalization and Death After COVID‐19 Diagnosis Among Patients With Rheumatic Disease: An Analysis of Veterans Affairs Data
por: Gabriela Schmajuk, et al.
Publicado: (2021)